F. Christopher Zusi

1.3k citations

19 papers · 1.0k indexed · h-index 13

Co-authors: James R. Burke Yuping Qiu Kim W. McIntyre Mark A. Pattoli John F. MacMaster Kurt R. Gregor Patrick Brassil Xiaoxia Yang
Topics: Retinoids in leukemia and cellular processes (6 papers)NF-κB Signaling Pathways (6 papers)Immune Response and Inflammation (3 papers)
Cited by: Cancer Research Immunology Biochemistry
Journals: Journal of Biological Chemistry Pharmaceutical Research Journal of Pharmaceutical Sciences
Partner nations: United States Germany Malaysia

In The Last Decade

F. Christopher Zusi

18 papers receiving 1.0k citations

Peers

Countries citing papers authored by F. Christopher Zusi

Since Specialization

Citations

This map shows the geographic impact of F. Christopher Zusi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Christopher Zusi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Christopher Zusi more than expected).

Fields of papers citing papers by F. Christopher Zusi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Christopher Zusi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Christopher Zusi. The network helps show where F. Christopher Zusi may publish in the future.

Co-authorship network of co-authors of F. Christopher Zusi

This figure shows the co-authorship network connecting the top 25 collaborators of F. Christopher Zusi. A scholar is included among the top collaborators of F. Christopher Zusi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Christopher Zusi. F. Christopher Zusi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Design and synthesis of a novel series of (1′S,2R,4′S)-3H-4′-azaspiro[benzo[4,5]imidazo[2,1-b]oxazole-2,2′-bicyclo[2.2.2]octanes] with high affinity for the α7 neuronal nicotinic receptor 2017 ·Bioorganic & Medicinal Chemistry Letters ·James A. Cook,F. Christopher Zusi,Matthew D. Hill,Haiquan Fang,Bradley C. Pearce,Hyunsoo Park,(unknown),Ivar M. McDonald,Linda J. Bristow,John E. Macor,Richard E. Olson	3
2	Design and synthesis of a novel series of 4-heteroarylamino-1′-azaspiro[oxazole-5,3′-bicyclo[2.2.2]octanes as α7 nicotinic receptor agonists 2. Development of 4-heteroaryl SAR 2017 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Dalton King,Ivar M. McDonald,James A. Cook,F. Christopher Zusi,Matthew D. Hill,Robert Mate,Haiquan Fang,Ronald J. Knox,(unknown),(unknown),(unknown),Yulia Benitex,(unknown),Nicholas J. Lodge,Robert Zaczek,Daniel G. Morgan,Linda J. Bristow,John E. Macor,Richard E. Olson	7
3	Discovery of a novel series of quinolone α7 nicotinic acetylcholine receptor agonists 2013 ·Bioorganic & Medicinal Chemistry Letters ·Ivar M. McDonald,Robert Mate,F. Christopher Zusi,Hong Huang,Debra J. Post-Munson,(unknown),(unknown),Robert L. Bertekap,Ronald J. Knox,Barbara Robertson,David Harden,Daniel G. Morgan,Nicholas J. Lodge,Steven I. Dworetzky,Richard E. Olson,John E. Macor	16
4	Synthesis and biological evaluation of 4-amino derivatives of benzimidazoquinoxaline, benzimidazoquinoline, and benzopyrazoloquinazoline as potent IKK inhibitors 2006 ·Bioorganic & Medicinal Chemistry Letters ·Françis Beaulieu,Carl Ouellet,Edward H. Ruediger,Makonen Belema,Yuping Qiu,Xuejie Yang,Jacques Banville,James R. Burke,Kurt R. Gregor,John F. MacMaster,Alain Martel,Kim W. McIntyre,Mark A. Pattoli,F. Christopher Zusi,Dolatrai M. Vyas	45
5	Retinoids as Therapeutic Agents: Today and Tomorrow 2005 ·Mini-Reviews in Medicinal Chemistry ·Valérie Vivat‐Hannah,F. Christopher Zusi	18
6	Progress in the Discovery of BACE Inhibitors 2005 ·Current Pharmaceutical Design ·Lorin A. Thompson,Joanne J. Bronson,F. Christopher Zusi	40
7	A HIGHLY SELECTIVE INHIBITOR OF IκB KINASE, BMS-345541, AUGMENTS GRAFT SURVIVAL MEDIATED BY SUBOPTIMAL IMMUNOSUPPRESSION IN A MURINE MODEL OF CARDIAC GRAFT REJECTION 2004 ·Transplantation ·(unknown),Jennifer Postelnek,Vojkan Susulic,Kim W. McIntyre,David J. Shuster,Yuping Qiu,F. Christopher Zusi,James R. Burke	20
8	Rational design of RAR‐selective ligands revealed by RARβ crystal stucture 2004 ·EMBO Reports ·Pierre Germain,Sabrina Kammerer,Efrén Pérez‐Santín,Carole Peluso‐Iltis,David R. Tortolani,F. Christopher Zusi,John E. Starrett,(unknown),Jean‐Paul Daris,Anne Marinier,Ángel R. de Lera,Natacha Rochel,Hinrich Gronemeyer	75
9	Synthesis of 1,1-diarylethylenes from an α-stannyl β-silylstyrene 2004 ·Tetrahedron Letters ·Makonen Belema,Van N. Nguyen,F. Christopher Zusi	19
10	An inhibitor of I?B kinase, BMS-345541, blocks endothelial cell adhesion molecule expression and reduces the severity of dextran sulfate sodium-induced colitis in mice 2003 ·Inflammation Research ·John F. MacMaster,Donna M. Dambach,Yuping Qiu,F. Christopher Zusi,James R. Burke,(unknown),K. K. Berry	46
11	BMS-345541 Is a Highly Selective Inhibitor of IκB Kinase That Binds at an Allosteric Site of the Enzyme and Blocks NF-κB-dependent Transcription in Mice 2003 ·Journal of Biological Chemistry ·James R. Burke,Mark A. Pattoli,Kurt R. Gregor,Patrick Brassil,John F. MacMaster,Kim W. McIntyre,Xiaoxia Yang,(unknown),Wendy Clarke,Joann Strnad,Yuping Qiu,F. Christopher Zusi	439
12	A highly selective inhibitor of IκB kinase, BMS‐345541, blocks both joint inflammation and destruction in collagen‐induced arthritis in mice 2003 ·Arthritis & Rheumatism ·Kim W. McIntyre,David J. Shuster,Kathleen M. Gillooly,Donna M. Dambach,Mark A. Pattoli,(unknown),Xiadi Zhou,Yuping Qiu,F. Christopher Zusi,James R. Burke	185
13	Selective retinoids and rexinoids in cancer therapy and chemoprevention 2002 ·Drug Discovery Today ·F. Christopher Zusi,Matthew V. Lorenzi,Valérie Vivat‐Hannah	59
14	Synergistic cytotoxicity exhibited by combination treatment of selective retinoid ligands with taxol (Paclitaxel). 2001 ·PubMed ·Valérie Vivat‐Hannah,(unknown),(unknown),Jean‐Paul Daris,(unknown),F. Christopher Zusi,Anne Marinier,Matthew V. Lorenzi,Marco M. Gottardis	26
15	Competitive, Reversible Inhibition of Cytosolic Phospholipase A2 at the Lipid-Water Interface by Choline Derivatives That Partially Partition into the Phospholipid Bilayer 1999 ·Journal of Biological Chemistry ·James R. Burke,Mark R. Witmer,F. Christopher Zusi,Kurt R. Gregor,(unknown),Ramesh Padmanabha,(unknown),Daniel J. Smith,Jeffrey Tredup,Radmila Micanovic,Susan P. Manly,Joseph J. Villafranca,Kenneth M. Tramposch	4
16	Evaluation of Retinoids as Therapeutic Agents in Dermatology 1994 ·Pharmaceutical Research ·Anita H. Lewin,(unknown),F. Christopher Zusi,(unknown),Gary S. Whiting,(unknown),(unknown),F.I. Carroll	15
17	The Requirement for a Retinoic Acid Lactone of 11-cis, 13-cis-Stereochemistry for Topical Dermatologic Activity 1994 ·Pharmaceutical Research ·Anita H. Lewin,R. Richard Goehring,F. Christopher Zusi,(unknown),(unknown),(unknown),(unknown),(unknown),F.I. Carroll	1
18	Biochemical and pharmacological properties of a new topical anti-inflammatory compound, 9-phenylnonanohydroxamic acid (BMY 30094) 1990 ·Inflammation Research ·Kenneth M. Tramposch,F. Christopher Zusi,Sandhya Amol Marathe,Paul Stanley,(unknown),Stefanie Steiner,(unknown)	8
19	Frozen Conformers of Clotrimazole: Reaction of Imidazole with 1-chloro-9-hydroxy-9-phenylxanthene 1979 ·Journal of Pharmaceutical Sciences ·(unknown),(unknown),F. Christopher Zusi	1

About F. Christopher Zusi

F. Christopher Zusi is a scholar working on Cancer Research, Toxicology and Organic Chemistry, having authored 19 papers that have together received 1.0k indexed citations. Recurring topics across this work include Retinoids in leukemia and cellular processes (6 papers), NF-κB Signaling Pathways (6 papers) and Immune Response and Inflammation (3 papers). The work is most often cited by research in Cancer Research (373 citations), Immunology (296 citations) and Biochemistry (55 citations). F. Christopher Zusi has collaborated with scholars based in United States, Germany and Malaysia. Frequent co-authors include James R. Burke, Yuping Qiu, Kim W. McIntyre, Mark A. Pattoli, John F. MacMaster, Kurt R. Gregor, Patrick Brassil, Xiaoxia Yang, Wendy Clarke and Joann Strnad. Their work appears in journals such as Journal of Biological Chemistry, Pharmaceutical Research and Journal of Pharmaceutical Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact